Scientific Advisory Board
T-CURX’s Scientific Advisory Board includes key opinion leaders with proven track records in achieving breakthrough discoveries in the fields of immunology and cancer medicine.
Prof. Michael Hudecek, MD
Chief Medical Officer, Co-FounderMichael is an internationally renowned expert in adoptive cellular and CAR T cell-based cancer therapies. He has published more than 60 peer-reviewed papers in the field and is a co-inventor on more than 10 patents and applications.
Prof. Hermann Einsele, MD
Scientific AdvisorHermann is a pioneering expert in hematological malignancies, adoptive immunotherapy, and T-cell therapy, with over 350 peer-reviewed publications and leadership roles at the University Hospital Würzburg and key oncology societies.
Prof. Christoph Rader, PhD
Scientific Advisor & Co-FounderChristoph is an internationally renowned expert in antibody-based cancer therapies, with a distinguished career at The Scripps Research Institute, the National Cancer Institute, and the University of Florida, and a strong track record in research, patents, and industry consulting.
Prof. Cameron Turtle, MD
Scientific AdvisorCameron is a globally recognized hemato-oncologist and expert in T-cell genetic engineering, with leadership roles at the University of Sydney and the Fred Hutchinson Cancer Center, and over 100 peer-reviewed publications in cancer immunotherapy.